Healthcare -
Biotechnology - NASDAQ - US
$ 36.17
20.2 %
$ 5.63 B
Market Cap
-361.7
P/E
TGTX - COST OF REVENUE
Cost of Revenue TGTX - TG Therapeutics, Inc.
14.1 M
LAST VALUE
322.93%
2 YEAR CAGR
176.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR